Editorial Advisory Board

By on May 8, 2012
Industry B N Singh, Managing Director, Alkem / IDMA Basudeo Narain Singh is the Managing Director of Alkem Laboratories. He is a post graduate in political science, and has nurtured the organisation in its early days. Singh is also the recent past president of Indian Drug Manufacturer’s Association (IDMA). Ajit Singh, Chairman, ACG WorldwideAjit Singh is Chairman of ACG Worldwide, Asia’s largest capsules and related machinery and packaging enterprise. He is a former President of the Indian Pharmaceutical Congress Association and Advisor to the US Pharmacopoeia for India. He was nominated as a Fellow of the American Association of Indian Pharmaceutical Scientists. He is Chairman of the India Affiliate of the International Society For Pharmaceutical Engineering (ISPE). Ajit Dangi, Danssen ConsultingDr Ajit Dangi has served as Director General, Organisation of Pharmaceutical Producers of India (OPPI) for over seven years. He is former President and Executive Director of Johnson & Johnson India where he served for 20 years in various capacities. He holds a Doctorate in Pharmaceutical Chemistry from University of London, England.
Finance Alok Gupta, Investment Director, HSBC Private Equity Advisors (India) Pvt. Ltd.Alok Gupta has recently joined HSBC Private Equity Advisors as part of the Venture Investment team. He is an engineering and economics graduate from BITS, Pilani and holds a PGDM from the Indian Institute of Management, Calcutta. He has worked extensively with companies in the Life Sciences, Healthcare, Biotechnology and Technology sectors on strategic and financial advisory projects. He was part of the start up team at YES BANK, where he commenced and developed the Life Sciences & Technology practice. Dr Tania Fernandez, Director – India, Burrill and CompanyDr Tania Fernandez joined the venture capital group of Burrill & Company in October 2004, and currently focuses on sourcing and evaluating US-India cross border and pure play Indian biotech/healthcare investment opportunities within venture as well as merchant banking. She secured her doctorate at the Cancer Research Institute, Tata Memorial Centre, India having been awarded the Indo-US scholarship from the National Institutes of Health. She previously gained operational experience at Hoechst Pharmaceuticals, Mumbai, India. She went on to do her post-doctoral specialisation at the College of Medicine, Texas A&M, later joining the National Cancer Institute, NIH in 1999 and was appointed Staff Scientist in 2000.
Industry Associations P D Sheth , VP, International Pharmaceutical FederationP D Sheth is Vice president of the International Pharmaceutical Federation (FIP). He is also the Professional Secretary of SEARPharm Forum, the South East Asian FIP-WHO Forum of National Pharmaceutical Associations. He retired after serving Ranbaxy Laboratories for 25 years in the capacity of Executive Vice President and Member on the Board. Gopal Nair, Vice Chairman, ISPEGopal Nair is Vice Chairman on the Board of ISPE India and the Editor of ISPE India’s newsletter. Currently the CEO of Grasp Enterprise, a consultancy headquartered in Mumbai, India. He was on the Board of Glaxo (GSK) till 2001, where he was the Executive Director on the Indian Board of Glaxo. Gopal Nair was also a Director in Burroughs Welcome and in Biddle Sawyer. Rajesh Shah, President, Indian Pharma Machinery Manufacturers AssociationRajesh Shah, President, IPMMA is an Engineer from Gujarat University. After working in a German company as a project Engineer, he decided to test his entrepreneurial spirit in 1980 and started his own manufacturing unit Maharshi Udyog in Ahmedabad. Shah has been a member of the IPMMA since its inception and has been taking a keen interest in the development of the association.
Academia Monisha Narke, Director, Klenzaids GMP AcademyMonisha Narke is the Vice President: Technology Utilisation of Klenzaids SciCentric Devices, Mumbai, India. As Director, Klenzaids GMP Academy, she organises technical seminars for students. She did her BE in Electrical Engineering, from VJTI, University of Bombay, and went on to do her MS in Industrial Engineering & Engineering Management from Stanford University, USA.
Pharma Tech Review Dr A K Singal, MD, NNE Pharmaplan IndiaDr A K Singal is the Founder/ Managing Director of NNE Pharmaplan India and is also on Board of NNE Pharmaplan Malaysia (KL). He was educated at Universities in Munich & Herne (Dusseldorf), Germany and did his MBBS; MS from Punjab University at Chandigarh and Delhi. He is also the founder director of ISPE India affiliate. He has more than 25 years experience in providing inputs for plants in Healthcare and Pharmaceutical sector in India and abroad. Pramod K Kulkarni, Director, Technolutions Projects Pvt LtdPramod K Kulkarni is the founder partner of Technolutions Projects Pvt Ltd, which provides consultancy services for various areas of the pharma and biotech industries. He is specifically involved with biotech and oncology facility design, containment and regulatory compliances. He has done his M Pharm from Department of Pharmaceutical Sciences, Nagpur University, a diploma in business management from Bharatiya Vidya Bhavan, Nagpur and has won many awards. R S Swaminathan, Managing Director, Spectrum Pharmatech Consultants Pvt LtdR S Swaminathan – Managing Director, Spectrum Pharmatech Consultants has nearly 30 years experience in design, engineering, execution and commissioning of basic chemical and pharma projects. He has done his Bachelor of Technology in Chemical Engineering and is an active member of the ISPE. He founded Spectrum Pharmatech Consultants in 1995.
Related Posts

Syngene announces 2nd year of STEM scholarship and mentorship program for women in collaboration with RICH

Oviya MedSafe launches pharmacovigilance consulting and drug safety service packages for RoW region

International Pharmaceutical Federation releases oath for pharmacists

DIPP constitutes IPR think tank

Aethlon Medical announces undetectable Ebola Virus in patient treated with Hemopurifier therapy

Pfizer posts Rs 269 crores revenue in quarter ended September 30, 2014

Govt bracing up to popularise traditional medicines
Comments (0)
Add Comment